紫元元:2023 年報
Ziyuan Yuan (08223) announced annual results. Profit attributable to shareholders of 145.63 million yuan decreased by 7.9% year-on-year
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue, people...
ZYY: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Ziyuanyuan (08223) plans to discount approximately 19.23% and issue 30 million subscription shares to raise about HK$43.5 million net
According to the Zhitong Finance App, Ziyuan (08223) announced that on December 29, 2023, the company plans to issue 15 million subscription shares to Yu Jianping and Zheng Zhihong respectively. The subscription price for each subscribed share is HK$1.47, a discount of about 19.23% from the closing price of HK$1.82 per share. Net funding of approximately HK$43.5 million is intended to be used for general working capital to develop the Group's financial leasing business and medical device and consumables trading business. On the same day, that is, the final end date of the placement agreement, the prerequisites for the placement agreement have not been met, and the proposed transactions under the placement agreement have expired and been terminated
Zi Yuanyuan (08223) plans to discount approximately 13.28%, place up to 40 million shares, place up to 40 million shares, net raise about HK$42.7 million
Zi Yuanyuan (08223) issued an announcement. On December 12, 2023, the company signed a placement agreement with the placement agent...
Zi Yuanyuan (08223.HK) plans to further develop medical device and consumables trading business
Gelonghui November 24 | Zi Yuanyuan (08223.HK) announced that on November 24, 2023, the company (“buyer”) signed a memorandum of understanding with He Chao, Shenzhen Yunrui Investment Limited Partnership (Limited Partnership) and Shenzhen Borui Cloud Investment Partnership (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares of Shenzhen Chuangda Yunrui Intelligent Technology Co., Ltd. (“Target Company”) and the buyer intended to inject capital into the target company. After the shares to be sold and capital injections are completed, the Group intends to own 51% of the target company's shares. The target company is a limited company established in China
ZYY: THIRD QUARTERLY REPORT 2023
ZYY: THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
Zi Yuanyuan (08223.HK) plans to buy Guangdong Dejiang Medical Products Co., Ltd. to develop medical device and consumables trading business
Gelonghui, October 27, Ziyuanyuan (08223.HK) announced that on October 27, 2023, the Company (“Buyer”) signed a Memorandum of Understanding with Hu Yang and Shenzhen Dejiang Investment Co., Ltd. (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares in Guangdong Dejiang Medical Products Co., Ltd. (“Target Company”). The target company is a limited company established in China, founded in 2017, dedicated to R&D, manufacturing and sales of medical physiotherapy equipment. The founding team of the target company comes from well-known companies in the industry and has many years of work experience in the medical device industry
ZYY: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
ZYY: INTERIM REPORT 2023
Ziyuan Yuan (08223.HK)'s interim earnings increased 23.3% to 176 million yuan
On August 11, GLONGHUI | Ziyuan (08223.HK) announced that in the six months ending June 30, 2023, the Group's revenue increased by about 23.3% to about RMB 175.6 million. The total profit and overall revenue attributable to company owners during this period was approximately RMB 6.1 million and RMB 8.1 million, respectively. The decrease in total profit and overall revenue attributable to company owners during this period was mainly due to a decrease in revenue and other net income and loss from the same period in 2022 (i) financial leasing services and maternal and child confinement services; and (ii) increased financing costs, which offset (i) medical devices
ZYY: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Ziyuanyuan (08223) has added an additional guarantee amount of about 106 million yuan in the past year to provide China Construction Bank with customer repayment obligations
According to the Zhitong Finance App, Ziyuanyuan (08223) announced that on August 30, 2022, Ruiheng, a wholly-owned subsidiary of the company, signed a 2022 cooperation agreement with China Construction Bank. China Construction Bank agreed to provide customers with a trade loan of no more than RMB 500 million to purchase dental equipment from Ruiheng. The individual loan term and amount of each trade loan shall not exceed 36 months and RMB 1 million, respectively. The trade loan can only be used to purchase dental medical equipment from Ruiheng. According to the 2022 cooperation agreement, the guarantor shall use China Construction Bank as the beneficiary to execute the guarantee
ZYY: DATE OF BOARD MEETING
ZYY To Go Ex-Dividend On June 8th, 2023 With 0.025 HKD Dividend Per Share
June 3rd - $ZYY(08223.HK)$ is trading ex-dividend on June 8th, 2023. Shareholders of record on June 9th, 2023 will receive 0.025 HKD dividend per share on July 13th, 2023. The ex-dividend date is
ZYY: FIRST QUARTERLY REPORT 2023
ZYY: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2023
Zi Yuanyuan: Date of board meeting
Zi Yuan Yuan (08223): The total amount of additional guarantees is about 208.43 million yuan
According to the Zhitong Finance App, Zi Yuanyuan (08223) issued an announcement. On August 30, 2022, Ruiheng, a wholly-owned subsidiary of the company, signed a 2022 cooperation agreement with China Construction Bank. According to this, China Construction Bank agreed to provide customers with a trade loan of no more than RMB 500 million to purchase dental medical equipment from Ruiheng. The individual loan term and amount of each trade loan shall not exceed 36 months and RMB 1 million respectively. The trade loan can only be used to purchase dental medical equipment from Ruiheng. According to the 2022 cooperation agreement, the guarantor shall use China Construction Bank to execute the guarantee for the beneficiaries.
No Data